SG 050/25
The US Food and Drug Administration (FDA) is proposing a requirement for standardized testing methods to detect and identify asbestos contamination in talc-containing cosmetic products.
The FDA proposal would mandate testing of talc-containing products by manufacturers in alignment with the Modernization of Cosmetics Regulation Act (MoCRA) to enhance consumer safety. Manufacturers would be required to utilize both polarized light microscopy (PLM) and transmission electron microscopy (TEM), combined with energy dispersive spectroscopy (EDS) and selected area electron diffraction (SAED), to detect asbestos in talc-containing cosmetic products. These methods are expected to provide a comprehensive approach to asbestos detection.
Testing would be required on representative samples from each batch or lot of the final talc-containing cosmetic products or the talc ingredient itself. Alternatively, manufacturers could rely on certificates of analysis (COA) from their suppliers, provided they verify the reliability of these certificates.
The proposed rule would also require manufacturers to maintain detailed records of asbestos testing methods (i.e. raw data and descriptions of testing methods/protocol). If manufacturers rely on supplier COAs, they must document verification of supplier testing. Records must be retained for at least three years and made available to the FDA within one business day upon request.
Failure to comply with testing or recordkeeping requirements would render the cosmetic product adulterated under the Federal Food, Drug and Cosmetic Act (FD&C Act). Additionally, any presence of asbestos in a cosmetic product or its talc ingredient would also deem the product adulterated, prohibiting its sale and distribution within the US market.
The comment period is open to industry stakeholders and the public until March 27, 2025.
Key terms under FDA-2023-N-4225 (RIN 0910–AI82)
Term | Definition under FDA-2023-N-4225 RIN 0910–AI82 |
---|---|
Cosmetics | Articles intended to be rubbed, poured, sprinkled or sprayed on, introduced into or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness or altering the appearance |
Asbestos | Amosite, chrysotile, crocidolite, asbestiform tremolite, actinolite, anthophyllite, winchite, richterite and other amphibole minerals in the asbestiform habit |
Representative sample | A sample consisting of multiple units selected based on rational criteria, such as random sampling, to ensure that it accurately represents the material being tested |
Timeline summary:
Timeline | Requirement |
---|---|
March 27, 2025 | Open comment close date |
30 days after final rule publication | Any final rule issued based on this proposal will take effect 30 days after the date of publication in the Federal Register |
Compliance provisions:
- Failure to test a talc ingredient or a talc-containing product in compliance with the proposed act renders the product adulterated under section 601(c) of the FD&C Act
- Failure to comply with recordkeeping requirements renders the cosmetic product adulterated under section 601(c) of the FD&C Act
- If asbestos is present in a talc-containing cosmetic product or talc ingredient, the product is adulterated under section 601(a) of the FD&C Act
With decades of experience, our global network of specialists provide expertise in all aspects of cosmetic, household care and hygiene testing and regulatory guidance. Our state-of-the-art facilities and technology will help you bring safe, effective and compliant products to market. Visit our website or contact us to learn more.
© SGS Société Générale de Surveillance SA. This publication or website is a property of SGS Société Générale de Surveillance SA. All contents including website designs, text, and graphics contained herein are owned by or licensed to SGS Société Générale de Surveillance SA. The information provided is for technical and general information purposes only and offers no legal advice. The information is no substitute for professional legal advice to ensure compliance with the applicable laws and regulations. All information is provided in good faith “as is”, and SGS Société Générale de Surveillance SA makes no representation or warranty of any kind, express or implied, and does not warrant that the information will be error-free or meet any particular criteria of performance or quality.
Units 303 & 305, 3/F, Building 22E,
Phase 3, Hong Kong Science Park,
Pak Shek Kok, New Territories, Hong Kong, China